[1]
Armstrong, A., Lebwohl, M., Stein Gold, L. and Jacobson, A. 2023. Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s133. DOI:https://doi.org/10.25251/skin.7.supp.133.